These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 25855554)

  • 41. Efficacy of two porcine reproductive and respiratory syndrome (PRRS) modified-live virus (MLV) vaccines against heterologous NADC30-like PRRS virus challenge.
    Chai W; Liu Z; Sun Z; Su L; Zhang C; Huang L
    Vet Microbiol; 2020 Sep; 248():108805. PubMed ID: 32828938
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of the Cross-Protective Efficacy of a Chimeric Porcine Reproductive and Respiratory Syndrome Virus Constructed Based on Two Field Strains.
    Shabir N; Khatun A; Nazki S; Kim B; Choi EJ; Sun D; Yoon KJ; Kim WI
    Viruses; 2016 Aug; 8(8):. PubMed ID: 27556483
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of concurrent vaccination with modified-live PRRSV-1 and PRRSV-2 vaccines against heterologous dual PRRSV-1 and PRRSV-2 challenge in late term pregnancy gilts.
    Yang S; Oh T; Kang I; Park SJ; Chae C
    Vet Microbiol; 2019 Dec; 239():108497. PubMed ID: 31767085
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Two Commercial Type 1 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV)-Modified Live Vaccines Reduce Seminal Shedding of Type 1 PRRSV but not Type 2 PRRSV in Infected Boars.
    Park C; Kim T; Choi K; Jeong J; Kang I; Park SJ; Chae C
    Transbound Emerg Dis; 2017 Feb; 64(1):194-203. PubMed ID: 25879825
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vaccination with a Porcine Reproductive and Respiratory Syndrome (PRRS) Modified Live Virus Vaccine Followed by Challenge with PRRS Virus and Porcine Circovirus Type 2 (PCV2) Protects against PRRS but Enhances PCV2 Replication and Pathogenesis Compared to Results for Nonvaccinated Cochallenged Controls.
    Niederwerder MC; Bawa B; Serão NV; Trible BR; Kerrigan MA; Lunney JK; Dekkers JC; Rowland RR
    Clin Vaccine Immunol; 2015 Dec; 22(12):1244-54. PubMed ID: 26446422
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of commercial genotype 1 porcine reproductive and respiratory syndrome virus (PRRSV) vaccine against field isolate of genotype 2 PRRSV.
    Ko SS; Seo SW; Sunwoo SY; Yoo SJ; Kim MH; Lyoo YS
    Vet Immunol Immunopathol; 2016 Apr; 172():43-9. PubMed ID: 27032502
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of host immune responses to homologous and heterologous type II porcine reproductive and respiratory syndrome virus (PRRSV) challenge in vaccinated and unvaccinated pigs.
    Li X; Galliher-Beckley A; Pappan L; Trible B; Kerrigan M; Beck A; Hesse R; Blecha F; Nietfeld JC; Rowland RR; Shi J
    Biomed Res Int; 2014; 2014():416727. PubMed ID: 24719862
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protection and immune response in pigs intradermally vaccinated against porcine reproductive and respiratory syndrome (PRRS) and subsequently exposed to a heterologous European (Italian cluster) field strain.
    Martelli P; Cordioli P; Alborali LG; Gozio S; De Angelis E; Ferrari L; Lombardi G; Borghetti P
    Vaccine; 2007 Apr; 25(17):3400-8. PubMed ID: 17276558
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of Type 2 PRRSV vaccine against Chinese and Vietnamese HP-PRRSV challenge in pigs.
    Lager KM; Schlink SN; Brockmeier SL; Miller LC; Henningson JN; Kappes MA; Kehrli ME; Loving CL; Guo B; Swenson SL; Yang HC; Faaberg KS
    Vaccine; 2014 Nov; 32(48):6457-62. PubMed ID: 25285886
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Peptide nanofiber hydrogel adjuvanted live virus vaccine enhances cross-protective immunity to porcine reproductive and respiratory syndrome virus.
    Li X; Galliher-Beckley A; Huang H; Sun X; Shi J
    Vaccine; 2013 Sep; 31(41):4508-15. PubMed ID: 23933333
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Commercial vaccines provide limited protection to NADC30-like PRRSV infection.
    Bai X; Wang Y; Xu X; Sun Z; Xiao Y; Ji G; Li Y; Tan F; Li X; Tian K
    Vaccine; 2016 Nov; 34(46):5540-5545. PubMed ID: 27712853
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Live porcine reproductive and respiratory syndrome virus vaccines: Current status and future direction.
    Renukaradhya GJ; Meng XJ; Calvert JG; Roof M; Lager KM
    Vaccine; 2015 Aug; 33(33):4069-80. PubMed ID: 26148878
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HSP70 fused with GP3 and GP5 of porcine reproductive and respiratory syndrome virus enhanced the immune responses and protective efficacy against virulent PRRSV challenge in pigs.
    Li J; Jiang P; Li Y; Wang X; Cao J; Wang X; Zeshan B
    Vaccine; 2009 Feb; 27(6):825-32. PubMed ID: 19070639
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessment of the efficacy of commercial porcine reproductive and respiratory syndrome virus (PRRSV) vaccines based on measurement of serologic response, frequency of gamma-IFN-producing cells and virological parameters of protection upon challenge.
    Zuckermann FA; Garcia EA; Luque ID; Christopher-Hennings J; Doster A; Brito M; Osorio F
    Vet Microbiol; 2007 Jul; 123(1-3):69-85. PubMed ID: 17376612
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of a DNA vaccine candidate co-expressing GP3 and GP5 of porcine reproductive and respiratory syndrome virus (PRRSV) with interferon α/γ in immediate and long-lasting protection against HP-PRRSV challenge.
    Du Y; Qi J; Lu Y; Wu J; Yoo D; Liu X; Zhang X; Li J; Sun W; Cong X; Shi J; Wang J
    Virus Genes; 2012 Dec; 45(3):474-87. PubMed ID: 22843314
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Virus replicon particles expressing porcine reproductive and respiratory syndrome virus proteins elicit immune priming but do not confer protection from viremia in pigs.
    Eck M; Durán MG; Ricklin ME; Locher S; Sarraseca J; Rodríguez MJ; McCullough KC; Summerfield A; Zimmer G; Ruggli N
    Vet Res; 2016 Feb; 47():33. PubMed ID: 26895704
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interaction between single-dose Mycoplasma hyopneumoniae and porcine reproductive and respiratory syndrome virus vaccines on dually infected pigs.
    Park SJ; Seo HW; Park C; Chae C
    Res Vet Sci; 2014 Jun; 96(3):516-22. PubMed ID: 24702900
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Different European-type vaccines against porcine reproductive and respiratory syndrome virus have different immunological properties and confer different protection to pigs.
    Díaz I; Darwich L; Pappaterra G; Pujols J; Mateu E
    Virology; 2006 Aug; 351(2):249-59. PubMed ID: 16712895
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of the efficacy of a trivalent vaccine mixture against a triple challenge with Mycoplasma hyopneumoniae, PCV2, and PRRSV and the efficacy comparison of the respective monovalent vaccines against a single challenge.
    Oh T; Park KH; Yang S; Jeong J; Kang I; Park C; Chae C
    BMC Vet Res; 2019 Oct; 15(1):342. PubMed ID: 31619295
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of live attenuated porcine reproductive and respiratory syndrome virus 2 strains to protect pigs from challenge with a heterologous Vietnamese PRRSV 2 field strain.
    Sattler T; Pikalo J; Wodak E; Revilla-Fernández S; Steinrigl A; Bagó Z; Entenfellner F; Claude JB; Pez F; Francillette M; Schmoll F
    BMC Vet Res; 2018 Apr; 14(1):133. PubMed ID: 29673363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.